Journal of Applied Physiology, Vol 66, Issue 3 1029-1034, Copyright © 1989 by American Physiological Society

ARTICLES

Modulation of endothelial GSH concentrations: effect of exogenous GSH and GSH monoethyl ester

M. F. Tsan, J. E. White and C. L. Rosano
Research Service, Veterans Administration Medical Center, New York.

We studied the effects of exogenous glutathione (GSH) and GSH monoethyl ester (GSH-MEE) on the enhancement of endothelial GSH concentrations. The preparation of GSH-MEE used contained 91% GSH-MEE, approximately 9% GSH diethyl ester (GSH-DEE) and a trace amount of GSH. Both GSH and GSH-MEE markedly stimulated the intracellular concentrations of GSH in endothelial cells. GSH-MEE was more potent than GSH. The enhancement of endothelial GSH concentration by exogenous GSH was completely inhibited by buthionine sulfoximine (BSO), a potent inhibitor of gamma-glutamylcysteine synthase, or acivicin (AT-125), an inhibitor of gamma-glutamyl transpeptidase, suggesting that it was due to the extracellular breakdown and subsequent intracellular resynthesis of GSH. In contrast, the effect of GSH-MEE was largely resistant to BSO and acivicin, suggesting that it was primarily due to transport of GSH-MEE followed by intracellular hydrolysis. The GSH-MEE preparation, which contained 9% GSH-DEE, at concentrations of 2 mM or higher caused vacuolization of endothelial cells. The enhancement of GSH concentrations by exogenous GSH, but not by GSH-MEE, protected endothelial cells against H2O2-induced injury.

This article has been cited by other articles:

				Y. Fu, S. Zheng, S. C. Lu, and A. Chen Epigallocatechin-3-gallate Inhibits Growth of Activated Hepatic Stellate Cells by Enhancing the Capacity of Glutathione Synthesis Mol. Pharmacol., May 1, 2008; 73(5): 1465 - 1473. [Abstract] [Full Text] [PDF]

				L. L. JI Exercise-induced Modulation of Antioxidant Defense Ann. N.Y. Acad. Sci., April 1, 2002; 959(1): 82 - 92. [Abstract] [Full Text] [PDF]

				P. R. Ramires and L. L. Ji Glutathione supplementation and training increases myocardial resistance to ischemia-reperfusion in vivo Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H679 - H688. [Abstract] [Full Text] [PDF]

				K. Kugiyama, Y. Miyao, T. Sakamoto, H. Kawano, H. Soejima, S. Miyamoto, M. Yoshimura, H. Ogawa, S. Sugiyama, and H. Yasue Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H264 - H271. [Abstract] [Full Text] [PDF]

				W. MacNee Oxidants/Antioxidants and COPD Chest, May 1, 2000; 117(5_suppl_1): 303S - 317S. [Abstract] [Full Text] [PDF]

				I. Rahman and W. MacNee Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1067 - L1088. [Abstract] [Full Text] [PDF]

				W. MACNEE and I. RAHMAN Oxidants and Antioxidants as Therapeutic Targets in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S58 - 65. [Abstract] [Full Text] [PDF]

				K. Kugiyama, M. Ohgushi, T. Motoyama, O. Hirashima, H. Soejima, K. Misumi, M. Yoshimura, H. Ogawa, S. Sugiyama, and H. Yasue Intracoronary Infusion of Reduced Glutathione Improves Endothelial Vasomotor Response to Acetylcholine in Human Coronary Circulation Circulation, June 16, 1998; 97(23): 2299 - 2301. [Abstract] [Full Text] [PDF]